Asker Healthcare Group AB (OSTO:ASKER) Beneish M-Score: -2.63 (As of Jul. 03, 2026)


OSTO:ASKER Asker Healthcare Group AB OSTO:ASKER
13 GF Score
Price kr84.95
! 3 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB Beneish M-Score?

Asker Healthcare Group AB OSTO:ASKER +1.13% 13 Beneish M-Score is -2.63 as of Jul. 03, 2026. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 112 Medical Distribution companies, Asker Healthcare Group AB ranks better than 62.5% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.63 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Asker Healthcare Group AB's Beneish M-Score or its related term are showing as below:

OSTO:ASKER' s Beneish M-Score Range Over the Past 10 Years
Min: -2.63   Med: -2.58   Max: -2.52
Current: -2.63

During the past 4 years, the highest Beneish M-Score of Asker Healthcare Group AB was -2.52. The lowest was -2.63. And the median was -2.58.


Asker Healthcare Group AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB Beneish M-Score Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 0.00 -2.52

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.52 -2.63

OSTO:ASKER vs MCK, CAH, COR: Beneish M-Score Comparison

For the Medical Distribution subindustry, Asker Healthcare Group AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asker Healthcare Group AB Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Asker Healthcare Group AB's Beneish M-Score falls into.


OSTO:ASKER
13GF Score
Asker Healthcare Group AB OSTO:ASKER
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Asker Healthcare Group AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0922+0.528 * 0.966+0.404 * 1.011+0.892 * 1.1124+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.049+4.679 * -0.058751-0.327 * 1.1184
=-2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was kr2,725 Mil.
Revenue was 4521 + 4676 + 4129 + 3987 = kr17,313 Mil.
Gross Profit was 1864 + 1929 + 1683 + 1630 = kr7,106 Mil.
Total Current Assets was kr5,853 Mil.
Total Assets was kr17,753 Mil.
Property, Plant and Equipment(Net PPE) was kr1,888 Mil.
Depreciation, Depletion and Amortization(DDA) was kr0 Mil.
Selling, General, & Admin. Expense(SGA) was kr5,986 Mil.
Total Current Liabilities was kr4,477 Mil.
Long-Term Debt & Capital Lease Obligation was kr5,008 Mil.
Net Income was 193 + 130 + 142 + 129 = kr594 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0 Mil.
Cash Flow from Operations was 419 + 568 + 439 + 211 = kr1,637 Mil.
Total Receivables was kr2,243 Mil.
Revenue was 3995 + 4303 + 3597 + 3669 = kr15,564 Mil.
Gross Profit was 1629 + 1696 + 1405 + 1441 = kr6,171 Mil.
Total Current Assets was kr4,859 Mil.
Total Assets was kr14,234 Mil.
Property, Plant and Equipment(Net PPE) was kr1,435 Mil.
Depreciation, Depletion and Amortization(DDA) was kr0 Mil.
Selling, General, & Admin. Expense(SGA) was kr5,130 Mil.
Total Current Liabilities was kr2,802 Mil.
Long-Term Debt & Capital Lease Obligation was kr3,998 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2725 / 17313) / (2243 / 15564)
=0.157396 / 0.144115
=1.0922

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6171 / 15564) / (7106 / 17313)
=0.396492 / 0.410443
=0.966

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5853 + 1888) / 17753) / (1 - (4859 + 1435) / 14234)
=0.563961 / 0.557819
=1.011

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=17313 / 15564
=1.1124

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1435)) / (0 / (0 + 1888))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5986 / 17313) / (5130 / 15564)
=0.345752 / 0.329607
=1.049

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5008 + 4477) / 17753) / ((3998 + 2802) / 14234)
=0.534276 / 0.477729
=1.1184

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(594 - 0 - 1637) / 17753
=-0.058751

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Asker Healthcare Group AB has a M-score of -2.63 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.63 mean?
Asker Healthcare Group AB (OSTO:ASKER) has a Beneish M-Score of -2.63 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Asker Healthcare Group AB and its competitors. According to the industry distribution chart, Asker Healthcare Group AB ranks #42 out of 112 companies in the Medical Distribution industry, placing it in the top 37.5%.
Is Asker Healthcare Group AB's Beneish M-Score too high?
Asker Healthcare Group AB's current Beneish M-Score is -2.63. Based on the distribution chart, Asker Healthcare Group AB ranks #42 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Beneish M-Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #42 out of 112 companies for Beneish M-Score. This puts Asker Healthcare Group AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Asker Healthcare Group AB and its competitors. Asker Healthcare Group AB's current Beneish M-Score is -2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current Beneish M-Score of -2.63. The current Beneish M-Score is -2.63. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current Beneish M-Score is -2.63 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKERs:UKI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score

Get the complete analysis for OSTO:ASKER

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr84.95
Price